Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

According to the American Cancer Society, around 10-15% of breast cancers are triple-negative breast cancer.
News | Breast Imaging
Georgia Cancer Center Researcher Receives $1.7M Grant to Study Aggressive Form of Breast Cancer 
October 4, 2021 — Understanding the role a certain molecule plays in both cancer cells, as well as the cells tasked to ...
Time
arrow
Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).
Feature | Radiation Therapy
Radiation Therapy Reprograms Heart Cells to Younger State

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%
News | Radiation Oncology
Global $5.8 Billion Radiotherapy Devices 2021 Market Report

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
News | Prostate Cancer
Metastatic Prostate Cancer Comes in Two Forms, Which Could Guide Treatment

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.
News | Artificial Intelligence
Owkin and Cleveland Clinic Develop AI Model that Predicts Liver Cancer Prognosis

September 24, 2021 — Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to ...

Time September 24, 2021
arrow
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report
News | Radiation Therapy
Surface Guided Radiation Therapy Market Outlook

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.
News | Lung Imaging
$3M Grant Establishes Center to Combat Racial Inequities in Lung Cancer

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
Paige Prostate, is the first artificial intelligence (AI)-based software designed to identify an area of interest on the prostate biopsy image with the highest likelihood of harboring cancer so it can be reviewed further by the pathologist if the area of concern has not been identified on initial review.
News | Digital Pathology
FDA Authorizes Software That Can Help Identify Prostate Cancer

September 22, 2021 — The U.S. Food and Drug Administration authorized marketing of software to assist medical ...

Time September 22, 2021
arrow
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.
News | Radiation Oncology
New Research Guidelines Will Boost Interventional Oncology Research

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  
News | Radiation Oncology
Research Shows a Struggle to Keep Up With the Pace of Change in Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology
IBA and SCK CEN Join Forces to Enable Production of Actinium-225

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

Time September 17, 2021
arrow
Bicameral legislation in U.S. House and Senate designed to address equity issues in patient access and affordability for innovative diagnostic radiopharmaceuticals
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Supports Timely Consideration and Passage of the FIND Act of 2021 by U.S. Congress

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)
Feature | PET Imaging | By Todd Sasser, Ph.D.
The Role of PET Imaging in Preclinical Oncology

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

Time September 14, 2021
arrow
Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, to enable real-time therapeutic guidance of biology-guided radiotherapy (BgRT) in prostate cancer using the RefleXion X1 platform. 
News | PET Imaging
Lantheus and RefleXion Announce Collaboration with Potential to Improve Future Prostate Cancer Treatment

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
arrow
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus
News | Radiation Oncology
Oncology Research Rebounds from Pandemic Low, But Shows Cancer Patients Need Attention After COVID-19 Recovery

September 13, 2021 — At the opening press conference of the ESMO Congress 2021, President Solange Peters announced that ...

Time September 13, 2021
arrow
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments
News | ASTRO
ASTRO Submits RO Model Comment Letters to CMS

September 9, 2021 — The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for ...

Time September 09, 2021
arrow
News | PET Imaging
Researchers Identify Mechanism That Can Help Guide Development of New STING-activating Drugs Using Imaging

September 8, 2021 — A new study from scientists at the UCLA Jonsson Comprehensive Cancer Center found that emerging ...

Time September 08, 2021
arrow
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.
News | Artificial Intelligence
Artificial Intelligence Could Help Diagnose Lung Cancer a Year Earlier

September 8, 2021 — An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) ...

Time September 08, 2021
arrow
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA)
Sun Nuclear Highlights Expanded Machine QA Capabilities

September 2, 2021 — At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive ...

Time September 02, 2021
arrow
Featured in the ESTRO scientific program, three members of the Sun Nuclear SunCHECK Platform Customer Advisory Board will present on breakthrough findings from their use of SunCHECK software for independent, automated Machine QA and Patient QA, featuring in-vivo dosimetry.
News | Quality Assurance (QA)
Multi-Year Studies from Sun Nuclear’s SunCHECK Platform Customer Advisory Board Presented at ESTRO 2021

September 1, 2021 — Sun Nuclear Corporation announced that as part of the ESTRO 2021 Congress, held August 27 – 31 in ...

Time September 01, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now